✦ LIBER ✦

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)

✍ Scribed by M.Ashequl Islam; James C Blankenship; Craig Balog; Elias A Iliadis; A.Michael Lincoff; James E Tcheng; Robert M Califf; Eric J Topol

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potent complementary clinical benefit of

✍ A.Michael Lincoff 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Effect of eptifibatide on angiographic c

✍ James C Blankenship; Kristina N Sigmon; Karen S Pieper; Conor O’Shea; Barbara E 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Complementary effects of thienopyridine

✍ Jean-Pierre Dery; Mark E. Campbell; Jasmine Mathias; Karen S. Pieper; Robert A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

Benefit of bolus-only platelet glycoprot

✍ Jonathan D. Marmur; Cristina A. Mitre; Elliot Barnathan; Erdal Cavusoglu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Abciximab and angiographic restenosis af

✍ Helmut Schühlen; Adnan Kastrati; Julinda Mehilli; Jörg Hausleiter; Josef Dirschi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Provisional glycoprotein IIb/IIIa blocka

✍ J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. H 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 179 KB